Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons in chronic viral hepatitis.

R Müller1

  • 1Abteilung für Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover.

Hepato-Gastroenterology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left ventricular filling behaviour in ultra endurance and amateur athletes: a stress Doppler-echo study.

International journal of sports medicine·1992
Same author

Analysis of temperature-sensitive functions of Fos: lack of a correlation between transformation and TRE-dependent trans-activation.

Oncogene·1992
Same author

Purification and properties of 4-halobenzoate-coenzyme A ligase from Pseudomonas sp. CBS3.

Biological chemistry Hoppe-Seyler·1992
Same author

Microtubule-associated proteins 1A and LC2. Two proteins encoded in one messenger RNA.

The Journal of biological chemistry·1992
Same author

Assignment of two human cell cycle genes, CDC25C and CCNB1, to 5q31 and 5q12, respectively.

Genomics·1992
Same author

[Ambulatory phlebectomy].

Therapeutische Umschau. Revue therapeutique·1992
Same journal

Palliative Surgery for Gastric Cancer with Gastric Outlet Obstruction or Anemia due to Tumor Bleeding.

Hepato-gastroenterology·2016
Same journal

A Novel "Artery First" Approach Allowing Safe Resection in Laparoscopic Pancreaticoduodenectomy: The Uncinate Process First Approach.

Hepato-gastroenterology·2016
Same journal

A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer.

Hepato-gastroenterology·2016
Same journal

A Novel Approach for Endoscopic Papillary Balloon Dilation with the Guidewire Left in the Pancreatic Duct to Ensure Pancreatic Stenting.

Hepato-gastroenterology·2016
Same journal

Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?

Hepato-gastroenterology·2016
Same journal

Hydrodynamics Analysis and CFD Simulation of Portal Venous System by TIPS and LS.

Hepato-gastroenterology·2016
See all related articles

Interferon therapy shows limited efficacy for chronic viral hepatitis. While alpha interferon offers some benefit for Hepatitis B and C, high relapse rates and lack of effective treatments for Hepatitis D highlight the need for improved therapies.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Interferons are crucial for the innate immune response against viral infections.
  • Chronic viral hepatitis, including Hepatitis B, C, and D, poses significant global health challenges.
  • Current treatment strategies for chronic viral hepatitis are evolving.

Purpose of the Study:

  • To review the types of interferons and their impact on chronic viral hepatitis.
  • To evaluate the efficacy and limitations of interferon therapy for Hepatitis B, C, and D.

Main Methods:

  • Review of existing literature on interferon therapy for chronic viral hepatitis.
  • Analysis of response rates and outcomes for Hepatitis B, C, and D.
  • Assessment of treatment effectiveness based on clinical markers and patient populations.

Related Experiment Videos

Main Results:

  • Alpha interferon treatment (4-6 months) yields approximately 30% response rates in non-immunosuppressed Caucasian patients with Hepatitis B.
  • Hepatitis C treatment with alpha interferon shows response rates of about 50% based on aminotransferase levels, but relapse is common.
  • Hepatitis D treatment with alpha interferon provides only transient or minimal benefit to a small patient subset.

Conclusions:

  • Interferon therapy demonstrates modest efficacy for Hepatitis B and C, with significant limitations including high relapse rates.
  • Effective treatment protocols for chronic Hepatitis D remain elusive, with interferons offering little benefit.
  • Further research is needed to develop more effective and sustainable therapies for chronic viral hepatitis.